Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Barbara Sankofi
Tamoxifen targets Wisp2 to impair subcutaneous adipocyte progenitor self-renewal and adipogenic differentiation
Abstract Breast cancer endocrine therapy, including tamoxifen, systemically disrupts estrogen receptor signaling and increases type 2 diabetes (T2D) risk in women. Hyperplastic adipose tissue expansion, especially in subcutaneous depots, facilitates nutrient storage and attenuates inflammation during a chronic positive energy balance and is impaired in the absence of estrogen.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barbara
Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack